PPARG and type 2 diabetes mellitus: Although thiazolidinediones, which are agonists for PPARγ, a master regulator of adipocyte differentiation and maturation, were developed and widely used for the treatment of T2D, this class of drugs often causes side effects, such as weight gain, bone fracture, and fluid retention.